Anglais

Liberalizing shop opening hours

A version of this article was published in the EU Reporter, February/March 2007, p. 21 under the title « Talking shop ». During the ‘90s, Denmark, Greece, the Netherlands, England, Austria and Japan have liberalized their shop opening hours. The debate rages over the same issue nowadays in the city of Geneva, France and Quebec.

→ Lire la suite

AMD-Intel: Are price cuts anticompetitive?

A version of this article was published in the Wall Street Journal on March 1st, 2007. The world’s No. 1 chipmaker, Intel, has been the target of a series of antitrust probes and lawsuits around the globe. Attempts to thwart them amount to interfering with, and detracting to, the ways through which firms strive to provide the best possible value to consumers.

→ Lire la suite

Social Security – The ineffectiveness and the pernicious effects of health cost containment policies in France

Paris, 9 March 2007 – While the issue of the future of the health system is conspicuous by its absence during the presidential campaign and that a showdown is pitting unions of general practitioners against public health insurance over tariffs, time has come to rethink seriously health cost containment policies in France, according to a new study released by the Institut économique Molinari. “We must yield to evidence. Whereas letting…

→ Lire la suite

Brussels’s misguided campaign against tax breaks

Article published by the Financial Times on February 23, 2007, p. 13. The European Commission seems to recognise no limits in its drive to impose tax harmonisation across Europe. Having issued a sanction against Luxembourg last July for its preferential tax regime pertaining to holding companies, Brussels is now trying to put pressure on countries even outside the EU by targeting Swiss cantonal tax competition and their tax breaks and…

→ Lire la suite

Bureaucratic drug delisting: the French example

Article published in the EU Reporter (January-February2007, p. 30). In their endeavor to cut back on costs, public health systems throughout Europe resort more and more to drug delisting. Beyond the fact that they may prove to be inefficient, these measures also reflect an alarming trend towards bureaucratization of healthcare by these monopolistic schemes. France provides a fitting example of this trend.

→ Lire la suite

Health myths in France – More competition, not cost containment, is the solution, according to the French Institut économique Molinari

9 January 2007 – Since 1945-46, the French system of Social Security has been imposing a mandatory health insurance and thus has a captive clientele – as the insured are compelled to finance it. This system has been, and is still, justified in a great measure in the opinion of the general public on grounds that it allegedly leads the French people to become equal in health and provides financing…

→ Lire la suite

German-style reference pricing for drugs – the need is urgent to give a free choice of insurance to all Germans, says a study

December 11, 2006 – Doctors, dentists, pharmacists and other health care workers in Germany have been strongly protesting against the new cost containment health care reform. « This reform will simply lead the healthcare system into the cul-de-sac of centralized bureaucracy », according to their last joint statement during the national strike on December, 4, 2006. “The main effects of reference pricing are very similar: it ends up with a bureaucratization of…

→ Lire la suite

Europe: Don’t Vote with Your Feet

Article published on TCS Daily on October 17, 2006. If you are fed up with paying taxes, you'll certainly like the idea of tax competition. It gives the opportunity to escape fiscal pressure from your own government by eventually "voting with your feet" to other jurisdictions with more favourable tax regimes. And it gives strong incentives for governments elsewhere to lower their own taxes.

→ Lire la suite

Hidden defects in the authorisation procedure of placing drugs on the market

13 June 2006 – The French Agency for the medical safety of health products (AFSSAPS or, Agence française de sécurité sanitaire des produits de santé) requires pharmaceutical laboratories to carry out a series of safety and effectiveness tests for every new product, before authorising them to be placed on the market. It thus poses as guardian of French health. The task is complex because trades-off between safety, effectiveness and the…

→ Lire la suite

The Real Abuse

Article published by TCSDaily on April 26, 2006.

→ Lire la suite
Bouton retour en haut de la page